{"article_title": "5 Best Biotech Stocks to Buy Now", "article_keywords": ["biotech", "buy", "risk", "investors", "johnson", "healthcare", "2015", "stocks", "best", "care"], "article_url": "http://investorplace.com/2014/10/biotech-stocks-to-buy-now/", "article_text": "Biotech stocks to buy aren\u2019t exactly the most popular investments on Wall Street right now.\n\nThe \u201crisk on\u201d environment of 2013 seems to have evaporated, with volatility heating up and many investors taking shelter in old stalwarts like consumer staples and even bond funds. Biotech stocks are often seen as risky and more speculative by investors, particularly those who prefer entrenched health care stocks like Johnson & Johnson (JNJ) or Pfizer (PFE) in Big Pharma.\n\nBut if you\u2019re looking for outperformance in 2015, then the modest risk but big-time potential of biotech stocks could be just what the doctor ordered.\n\nThere are many reasons to be bullish on healthcare stocks broadly \u2014 both because of the recession-proof nature of the sector, and the growth that is sure to come from greater access to insurance via Obamacare and demographic tailwinds thanks to aging Boomers who will need more care and medications.\n\nBiotech stocks in particular are among the best stocks to buy because healthcare megacaps face questions of competition abroad, a strong dollar holding back international profits in 2015 and, of course, patent expirations on blockbuster drugs from years past\n\nIf you want to invest in tomorrow\u2019s cutting edge treatments to day, the best biotech stocks to buy are the way to do just that.\n\nNext Page", "article_metadata": {"description": "Discovery why biotech stocks are unlikely candidates for blowout performance in 2015.", "generator": "WordPress 4.4.3", "og": {"site_name": "InvestorPlace", "description": "Discovery why biotech stocks are unlikely candidates for blowout performance in 2015.", "title": "5 Best Biotech Stocks to Buy Now | InvestorPlace", "locale": "en_US", "image": {"width": 630, "identifier": "http://investorplace.com/wp-content/uploads/2014/06/biotech-laboratory-scientist-630-ISP.jpg", "height": 478}, "updated_time": "2014-10-20T11:36:06-04:00", "url": "http://investorplace.com/2014/10/biotech-stocks-to-buy-now/", "type": "article"}, "twitter": {"description": "Discovery why biotech stocks are unlikely candidates for blowout performance in 2015.", "creator": "@JeffReevesIP", "image": "http://investorplace.com/wp-content/uploads/2014/06/biotech-laboratory-scientist-630-ISP.jpg", "title": "5 Best Biotech Stocks to Buy Now | InvestorPlace", "site": "@InvestorPlace", "card": "summary"}, "robots": "noodp", "fb": {"admins": 100002035369734}, "yandex-verification": "7449d54f0a1869d7", "article": {"publisher": "https://www.facebook.com/investorplace", "section": "Stocks to Buy", "published_time": "2014-10-20T11:02:54-04:00", "modified_time": "2014-10-20T11:36:06-04:00", "author": "investorplace"}, "keywords": "markets, biotech stocks to buy, biotech stocks, stocks to buy, biotechs", "google-site-verification": "5MtKaaO4K0OK-C2y-n9MKUc_WzF9GSkH0fLgruR0TKM", "pubdate": 20141020, "viewport": "width=device-width, initial-scale=1.0", "news_keywords": "markets, biotech stocks to buy, biotech stocks, stocks to buy, biotechs"}, "article_summary": "Biotech stocks in particular are among the best stocks to buy because healthcare megacaps face questions of competition abroad, a strong dollar holding back international profits in 2015 and, of course, patent expirations on blockbuster drugs from years pastIf you want to invest in tomorrow\u2019s cutting edge treatments to day, the best biotech stocks to buy are the way to do just that.\nBiotech stocks to buy aren\u2019t exactly the most popular investments on Wall Street right now.\nBiotech stocks are often seen as risky and more speculative by investors, particularly those who prefer entrenched health care stocks like Johnson & Johnson (JNJ) or Pfizer (PFE) in Big Pharma.\nBut if you\u2019re looking for outperformance in 2015, then the modest risk but big-time potential of biotech stocks could be just what the doctor ordered.\nThe \u201crisk on\u201d environment of 2013 seems to have evaporated, with volatility heating up and many investors taking shelter in old stalwarts like consumer staples and even bond funds."}